Taiwanese company United Biomedical Inc. (UBI) Asia on Wednesday applied for emergency use authorization (EUA) in Taiwan for its COVID-19 vaccine candidate, after releasing the interim results of its Phase 2 clinical trials last weekend, according to its subsidiary.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
District court again grants bail to ex-Taipei Mayor Ko Wen-je (update)
09/15/2025 09:27 PM - Politics
Guatemala celebrates Independence Day in Taiwan with reception, exhibit
09/15/2025 08:34 PM - Culture
In Ghost Festival event, Chiayi honors ghosts of all genders
09/15/2025 08:28 PM - Business
Alfa Romeo returns to Taiwan market
09/15/2025 07:56 PM - Business
Manufacturing sector's Q2 fixed asset investments up on IC expansion
09/15/2025 07:45 PM